Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Org Biomol Chem ; 17(16): 4043-4048, 2019 04 17.
Artigo em Inglês | MEDLINE | ID: mdl-30950479

RESUMO

Cytochrome c-poly(acrylic acid) (cyt c-PAA) conjugates with 34-fold enchancement in peroxidase turnover number (kcat) are reported. Cyt c-PAA conjugates were prepared by carbodiimide coupling. PAA with molecular weight (Mw) ranging from 1.8k to 250k g mol-1 were employed, and the effect of PAA Mw on peroxiodase kinetics was assessed. The kcat value increased with increased Mw of PAA, ranging from 0.077(±0.002) s-1 in the absence of PAA to 2.66(±0.08) s-1 for the conjugate of cyt c with 250k PAA. Enzymatic activity studies over pH 6-8 indicated improved activity for cyt c-PAA conjugates at neutral or slightly alkaline pH. Examination of the cyt c heme spectroscopy in the presence of H2O2 revealed that formation of compound III, a reactive intermediate that leads to enzyme inactivation, was supressed in cyt c-PAA conjugates. Thus, we suggest the kcat enhancement can be attributed to acidification of the pH microenvironment and inhibition of the formation of a reactive intermediate that deactivates cyt c during the catalytic cycle.


Assuntos
Resinas Acrílicas/metabolismo , Citocromos c/metabolismo , Peroxidases/metabolismo , Resinas Acrílicas/química , Citocromos c/química , Etildimetilaminopropil Carbodi-Imida/química , Peróxido de Hidrogênio/química , Concentração de Íons de Hidrogênio , Estrutura Molecular
2.
Bull Exp Biol Med ; 163(6): 737-741, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29063329

RESUMO

We compared samples of microencapsulated naloxone prepared by using spray drying technique. 2-Hydroxypropyl-ß-cyclodextrin, sodium alginate, polycaprolactone, and carboxymethyl cellulose were used as the carriers. It was found that the combination of naloxone with sodium alginate was characterized by the highest naloxone content in the matrix and the lowest release rate (100% release time was 60 min). Using the model of respiratory disturbances caused by 10 ED50 fentanyl (anesthetic effect), we studied the effects of naloxone-sodium alginate complex on the dynamics of CO2 concentration in the expired air. It was shown that treatment with the developed microencapsulated naloxone after fentanyl injection allowed reducing the therapeutic dose of the antagonist by more than 2 times and eliminated the necessity of repeated injections.


Assuntos
Portadores de Fármacos , Fentanila/intoxicação , Naloxona/farmacologia , Antagonistas de Entorpecentes/farmacologia , Entorpecentes/intoxicação , 2-Hidroxipropil-beta-Ciclodextrina/química , Alginatos/química , Animais , Animais não Endogâmicos , Carboximetilcelulose Sódica/química , Composição de Medicamentos/métodos , Liberação Controlada de Fármacos , Fentanila/antagonistas & inibidores , Fentanila/toxicidade , Ácido Glucurônico/química , Ácidos Hexurônicos/química , Cinética , Masculino , Naloxona/metabolismo , Antagonistas de Entorpecentes/metabolismo , Entorpecentes/toxicidade , Poliésteres/química , Ratos , Respiração/efeitos dos fármacos
3.
Eksp Klin Farmakol ; 76(1): 3-6, 2013.
Artigo em Russo | MEDLINE | ID: mdl-23461007

RESUMO

Technological parameters for the effective encapsulation of n-(1-phenethyl-4-piperidyl)propionanilide in poly(lactid-co-glycolide) (PLG) nanoparticles have been determined. Depending on the ratio of drug fractions adsorbed on the particle surface and associated with the polymer matrix, n-(1-phenethyl-4-piperidyl)propionanilide (200 microg/kg, i/m) loaded PLG nanospheres accelerated time onset and increased duration of sleep in rats: by a factor of 1.6 - 2.0 for polymer associated drug fraction within 40 - 60% and by a factor of 2.2 - 2.6 for polymer associated drug fraction within 60 - 80%. A similar increase of sleep duration was observed when free n-(1-phenethyl-4-piperidyl)-propionanilide was administered at doses within 400 - 500 microg/kg.


Assuntos
Portadores de Fármacos/química , Composição de Medicamentos/métodos , Hipnóticos e Sedativos/farmacologia , Ácido Láctico/química , Nanopartículas/química , Piperidinas/farmacologia , Ácido Poliglicólico/química , Sono/efeitos dos fármacos , Animais , Hipnóticos e Sedativos/química , Injeções Intramusculares , Masculino , Tamanho da Partícula , Piperidinas/química , Poloxâmero/química , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Ratos
4.
Stomatologiia (Mosk) ; 84(1): 33-5, 2005.
Artigo em Russo | MEDLINE | ID: mdl-15699976

RESUMO

The technique of local anesthesia by lidocain in combination with clonidine (clofelinum) as vasoconstrictor in the dose of 1 microg/kg was compared with local anesthesia by novocain in combination with adrenaline (1:200 000) or by lidocain without vasoconstrictor or by articain in combination with adrenaline (0.012 mg/ml). Lidocain use led to expressed tachycardia and considerable increase of cardiac oufput in moderate hypertension reactions. Adrenaline addition in anesthetic solution increases general peripheral resistance and all parameters of arterial pressure with simultaneous rise of heart contractions. Adrenaline substitution as local vasoconstrictor for clofelinum decreases sympathetic tension during operation, prevents hypertensive reactions as the result of general peripheral resistance decrease, stabilizes heart rhythm and basic indices of central hemodynamics, that testifies to its (technique) adequacy.


Assuntos
Agonistas alfa-Adrenérgicos/administração & dosagem , Anestesia Local/métodos , Anestésicos Locais/administração & dosagem , Lidocaína/administração & dosagem , Esfoliação de Dente , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Sistema Cardiovascular/efeitos dos fármacos , Clonidina , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Eletrocardiografia/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Frequência Cardíaca/fisiologia , Humanos , Injeções , Vasoconstrição/efeitos dos fármacos , Vasoconstrição/fisiologia
5.
FEBS Lett ; 463(1-2): 49-52, 1999 Dec 10.
Artigo em Inglês | MEDLINE | ID: mdl-10601636

RESUMO

The XPA protein is essential for both of the known modes of nucleotide excision repair (NER) in human cells: transcription-coupled repair (TCR) and global genome repair (GGR). In TCR, this protein is thought to be recruited to lesion sites in DNA at which RNA polymerase II is blocked and in GGR, by direct recognition of damages by repair protein complex containing XPC/HR23B or DNA damage-binding protein. However, details of the recruitment of the XPA protein in vivo are unknown. It was shown earlier that a portion of another NER protein, PCNA, which is completely extractable from non-S-phase mammalian nuclei, becomes insoluble after ultraviolet (UV) light irradiation and cannot be extracted by methanol or buffer containing Triton X-100. In the present study, we have found that UV light irradiation of human or Chinese hamster cells leads to decrease of extractability of the XPA protein by Triton X-100. Maximal insolubilization of the XPA protein is observed 1-4 h after irradiation but it is not detectable by 22 h. This effect is dose-dependent for UV light from 2.5 to 15 J/m(2) and is unaffected by the pre-treatment of cells with sodium butyrate, an inhibitor of histone deacetylation. The UV light-induced insolubilization of the XPA protein was also observed in two lines of Cockayne syndrome complementation group A cells, indicating that the effect is not dependent upon TCR. The results are discussed in relation to possible mechanisms of NER.


Assuntos
Dano ao DNA , Reparo do DNA , Proteínas de Ligação a DNA/química , Proteínas de Ligação a DNA/efeitos da radiação , Animais , Western Blotting , Células CHO , Síndrome de Cockayne/genética , Síndrome de Cockayne/metabolismo , Cricetinae , Proteínas de Ligação a DNA/genética , Detergentes/farmacologia , Relação Dose-Resposta à Radiação , Fibroblastos/química , Fibroblastos/efeitos dos fármacos , Fibroblastos/efeitos da radiação , Humanos , Octoxinol/farmacologia , Solubilidade/efeitos dos fármacos , Solubilidade/efeitos da radiação , Fatores de Tempo , Raios Ultravioleta , Proteína de Xeroderma Pigmentoso Grupo A
6.
Stomatologiia (Mosk) ; 80(5): 60-2, 2001.
Artigo em Russo | MEDLINE | ID: mdl-11696956

RESUMO

Arterial pressure (AP), heart rate, and stress index (estimated by ECG) were measured in 20 patients several minutes before dental treatment. Systolic AP was normal in 56% patients (mainly elderly), diastolic was normal in 50.5% and increased in 36% (particularly so in elderly patients). Heart rats was normal in 33% patients, the rest had bradycardia (6%) or tachycardia (61%); the latter condition was more typical of young patients and was paralleled by high systolic AP. 10.5% patients had normal stress index and in 87.5% it was increased, indicating extreme stress of the sympathoadrenal system. All 4 parameters were normal in 3.5% patients, half of whom were youths aged under 20 years. 10.5% examinees had three normal parameters, 32.5% had two normal parameters, and 37.5% had one normal parameters; 16% examinees had all parameters beyond the threshold values. The authors point to the double hazard of such a state (possible complications and decreased pain sensitivity) and emphasize the need in preventive measures to correct the general status of patients.


Assuntos
Ansiedade ao Tratamento Odontológico/fisiopatologia , Ansiedade ao Tratamento Odontológico/psicologia , Adaptação Fisiológica , Adaptação Psicológica , Adulto , Fatores Etários , Pressão Sanguínea , Feminino , Frequência Cardíaca , Humanos , Masculino , Pessoa de Meia-Idade , Fatores Sexuais , Estresse Psicológico/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA